Abstract
Pain experienced in the neonatal period has been shown to have serious short- and long-term consequences. It is also known that painkillers have side effects and should not be abused. The basis of proper pain management is assessment of pain, which in newborns is very difficult due to the lack of verbal communication. In these patients, behavioural scales are used to assess pain, but they have numerous shortcomings. For this reason, many newborns treated in the ICU are at risk of pain, so instrumental methods of detecting and assessing the severity of pain are being sought.
During three months, seven Polish NICUs conducted research with the use of NIPE and SCA monitors. After this time, the heads of these departments filled in questionnaires regarding their individual opinions on the usefulness of these devices.
All respondents found pain monitors useful in the NICU. The NIPE monitor was rated slightly higher, as its usefulness in assessing the effectiveness of analgosedation and in the management of patients in the postoperative period was better rated. The high acceptance of both devices by legal guardians of newborns is noteworthy.
It should be stated that in newborns, any way to improve pain monitoring is valuable. In the opinion of Polish experts, pain monitors are useful in NICU. The NIPE monitor was assessed a little higher and was considered useful in the assessment of analgosedation and in postoperative treatment. Pain monitors can provide valuable support for pain assessment in newborns treated in the NICU.
Keywords: Pain assessment, newborn, infant, NIPE monitor, SCA monitor, survey research
Introduction
Until the second half of the last century, it was believed that newborns were unable to feel pain; they thus underwent surgery without anaesthesia. Only in the mid-1980s it was proved that newborns who had anaesthesia during surgery had better short- and long-term treatment outcomes than those who were treated only with muscle relaxation [1]. Both short- and long-term negative consequences of pain experienced in the neonatal period have been demonstrated, concerning brain development, the functioning of the hypothalamic-pituitary-adrenal axis, hypersensitivity to pain stimuli, as well as cognitive and motor development disorders [2, 3, 4, 5, 6, 7, 8, 9]. This indicates the need for effective pain management in these patients; however, painkillers, especially opioids, can also cause complications, both early and late, although research results on this topic area are inconclusive [10, 11, 12, 13, 14, 15]. For these reasons, it is necessary to individually determine the indications for their use in newborns. The basis of rational pain treatment is the correct assessment of its occurrence and intensity. Over 25 years ago, it was proposed that pain should be treated as the ‘fifth vital sign’. As such, it should be monitored and documented in addition to parameters such as temperature, heart rate, blood pressure, and respiration [16,17]. However, the assessment of pain in newborns and infants is difficult due to the lack of verbal communication. It is based on behavioural or behavioural-physiological scales. These scales use the assessment of behaviour and selected life parameters. Although the usefulness of the scales has been proven, they have shortcomings, the most important of which are as follows: they are time-consuming; they require appropriately trained personnel (mainly nurses); they are subjective in the assessment of behavioural parameters; and there is lack of continuity of assessment, which may result in overlooking pain incidents [18,19].
As a result, despite the great progress made in this area in recent years, pain management in newborns is still insufficient [20, 21, 22, 23, 24]. Instrumental methods of pain assessment are an interesting support. Among them, methods based on the analysis of heart rate variability (HRV) and electrical skin conductance (SC) have been applied in newborns. The device that uses HRV is the NIPE monitor (Newborn Infant Pain Evaluation, Mdoloris Medical Systems, Loos, France), which uses an analog link to download the electrocardiography record from a standard cardiac monitor without contacting the patient directly. As a result of the analysis of respiratory HRV using complex mathematical algorithms, two indices are obtained – NIPEi and NIPEm, corresponding to the tension of the parasympathetic system. NIPEi is an instantaneous value and is primarily suitable for assessing procedural pain, and NIPEm is an average value that is mainly useful for assessing anaesthesia or analgosedation. Both indices take values from 1 to 100. According to the manufacturer's recommendation, the value of 50 is the pain threshold, so values ranging from 50 to 70 correspond to comfort, and nociceptive stimuli cause the index to fall below 50 [25, 26, 27]. The SCA monitor (Skin Conductance Algesimeter, SCA MedStorm Innovation, Norway) uses SC changes as a result of emotional sweat secretion with stimulation of the sympathetic nervous system. Three self-adhesive and atraumatic electrodes are placed on the skin of the sole of the foot of newborns and infants. The device measures and displays several parameters, of which, according to the manufacturer's recommendation, PPS (PPS – Peaks Per Second) is suitable for measuring the intensity of pain in newborns and infants. PPS levels are displayed on the monitor in five colours corresponding to different pain severity [28,29].
The aim of these studies was to find out the opinions of experts on the usefulness of instrumental pain monitoring and their subjective assessments regarding the use of the two types of monitors in neonates treated in the intensive care unit.
Material and methods
In the period 1.11.2018 – 31.01.2019, the studies that analysed the efficacy of NIPE and SC monitors for pain assessment were carried out in in seven centres in Poland – four NICU (neonatal intensive care units) and three paediatric anaesthesiology and intensive care units. The acceptance of the local ethical committee was granted. Study was approved by the local bioethics committee.
(270: 11.10.2018). Additionally, after three months of using both devices, a questionnaire study was conducted on the subjective opinions of experts on their practical usefulness. The heads of centres were asked to complete a questionnaire on the usefulness of instrumental pain monitoring, with the following answers to choose from: 1. definitely useful, 2. rather useful, 3. rather unhelpful, 4. definitely unhelpful, 5. I have no opinion. They were also asked to score, on a scale of 1 to 5, the following eight aspects of the use of both monitors: 1. suitability for the assessment of procedural pain, 2. suitability for monitoring the effectiveness of analgosedation, 3. suitability for patient management in the postoperative period, 4. approval from parents / legal guardians, 5. acceptance by nursing staff, 6. non-invasive measurement, 7. ease of use, 8. legibility of measurement results and ease of interpretation. For each monitor the sum of the points available in seven centres for each aspect was 35, and the total score available in seven centres was 280. The study was anonymous. At the time of filling in the questionnaires, the respondents did not know the results of the conducted scientific research in those seven centres.
Results
All respondents answered the question about the usefulness of instrumental pain monitoring in the studied group of patients. It was assessed as definitely useful in three centres and rather useful in four. All respondents scored both monitors in eight aspects. A summary of the scores for both devices is presented in Table 1.
Table 1.
Summary of the scores for both devices in seven medical centres.
| Assessed aspect | sum of points in seven centres | |
|---|---|---|
| NIPE | SCA | |
| Suitability for the assessment of procedural pain | 25 | 24 |
| Suitability for monitoring the effectiveness of analgosedation | 31 | 27 |
| Suitability for patient management in the postoperative period | 32 | 22 |
| Acceptance by parents / legal guardians | 33 | 32 |
| Acceptance by nursing staff | 32 | 23 |
| Non-invasive measurement | 34 | 29 |
| Ease of use | 34 | 24 |
| Readability of measurement results and ease of interpretation | 29 | 24 |
| Total points | 250 | 205 |
Discussion
All our respondents expressed the opinion that instrumental pain monitoring is definitely useful (4 respondents) or rather useful (3 respondents). Overall, the NIPE monitor received a higher score. The assessment of the usefulness of both devices in monitoring of procedural pain was similar and not very high. The usefulness of both monitors to assess the effectiveness of analgosedation was rated higher, while the NIPE monitor obtained a higher score than the SCA monitor. Similarly high was the rating of the NIPE monitor in terms of its usefulness in the postoperative period; this rating was also higher than the rating of the SCA monitor. The high level of acceptance by parents / legal guardians, which is very similar for both monitors, is noticeable. This is probably due to the non-invasive measurements made by NIPE and the low invasiveness of monitoring in the case of SCA monitor (the presence of additional electrodes on the newborn’s foot did not cause problems).
On the other hand, the NIPE monitor obtained a higher grade of acceptance by nurses due to non-invasiveness and lack of additional electrodes. In terms of the readability of the results and the ease of their interpretation, also the NIPE monitor was scored higher. This may be due to the ability to track both NIPE indices, to present a record with a time-varying curve, and to set thresholds for the desired values. The SCA monitor, on the other hand, offers the presentation of the measured values in colours, but their interpretation is unclear from a clinical point of view, and this monitor is also highly sensitive to artifacts. We did not find data on the subjective opinions of users on the usefulness of both monitors, and the results of scientific research on this topic are inconclusive. A significant amount of research has been done showing that the parameters measured by both devices change in response to pain stimuli, but there are very few publications regarding their practical utility in these patients in a clinical setting. Verweij et al. assessed the usefulness of NIPE in newborns after surgery performed under general anaesthesia and found that, although NIPE detects pain and discomfort in these patients, it does not correlate with the assessment using behavioural scales [30]. Gendras et al. and Cremillieux et al. found no significant correlation between the NIPE index and the PIPP-R score when performing painful procedures in preterm infants [31,32]. On the other hand, Walas et al., in a similar group of patients, found a significant decrease in this index three minutes after the stimulus. These measures correlated with the behavioural scale score, and the decline in the NIPE index occurred faster the stronger the behavioural response to pain was [33]. Similar results were obtained by Faye et al., who found a significant correlation between the NIPE index and the assessment of pain on the EDIN (Échelle Douleur Inconfort Nouveau-Né) scale, and Buyuktiryaki et al., who showed a correlation between the NIPE index and the assessment of pain intensity on this scale after the introduction of drainage of the pleural cavity in preterm newborns [27,34]. The results of studies on the usefulness of SCA in the assessment of pain in neonates are also inconclusive. In this group of patients, De Jesus et al., Pereira-da-Silva et al. and Eriksson et al. compared the results of SC measurements with the score on behavioural scales
in response to heel prick and found no correlation between them, although they noted increases in SC [35, 36, 37]. Storm described changes in SC caused by pain stimuli in preterm infants, but also found no correlation between them and the 4-point behavioural scale [29]. On the other hand, Tristão et al. observed in neonates a correlation between the increase in SC level and the modified COMFORT score in response to heel prick in infants, and Dadal et al. observed a correlation between the SC level and the NFSC score in postoperative infants [38,39].
In summary, it should be stated that in newborns, any way to improve pain monitoring is valuable. In the opinion of Polish experts, pain monitors are useful in NICU. The NIPE monitor was assessed a little higher and was considered useful in the assessment of analgosedation and in postoperative treatment. Pain monitors can provide valuable support for better care of newborns treated in the NICU.
Acknowledgements
Acknowledgments: no acknowledgments
Funding Statement
Funding information: no funding
Footnotes
Author’s contribution
Wojciech Walas1,3,5,6,8, Julita Latka-Grot2,3,4, Tomasz Szczapa2,3,,4,,5, Iwona Maroszyńska2,3,7, Magdalena Rutkowska2,3,7, Alicja Bartkowska-Śniatkowska2,3,7, Andrzej Piotrowski2,3,8
1- Conceptualization, 2- Data curation, 3- Investigation, 4- Methodology, 5- Project administration, 6- Supervision, 7- Writing – original draft, 8- Writing – review & editing.
Conflict of interest
Conflict of interest declaration: no conflict of interest
References
- 1.Anand KJ, Brown MJ, Causon RC, Christofides ND, Bloom SR, Aynsley-Green A. Can the human neonate mount an endocrine and metabolic response to surgery? J Pediatr Surg. 1985;20(1):41–8. doi: 10.1016/s0022-3468(85)80390-0. [DOI] [PubMed] [Google Scholar]
- 2.Ranger M, Grunau RE. Early repetitive pain in preterm infants in relation to the developing brain. Pain Manag. 2014;4(1):57–67. doi: 10.2217/pmt.13.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Anand KJS, Papanicolaou AC, Palmer FB. Repetitive neonatal pain and neurocognitive abilities in ex-preterm children. Pain. 2013;154(10):1899–901. doi: 10.1016/j.pain.2013.06.027. [DOI] [PubMed] [Google Scholar]
- 4.Grunau RE. Neonatal pain in very preterm infants: Long-term effects on brain, neurodevelopment and pain reactivity. Rambam Maimonides Med J. 2013;4(4):e0025. doi: 10.5041/RMMJ.101325. doi: 10.5041/RMMJ.101325. Chau CMY, Ranger M, Bichin M, Park MTM, Amaral RSC, Chakravarty M et al. Hippocampus, amygdala, and thalamus volumes in very preterm children at 8 years: Neonatal pain and genetic variation. Front Behav Neurosci. 2019;13:51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Chau CMY, Ranger M, Bichin M, Park MTM, Amaral RSC. Chakravarty M et al. Hippocampus, amygdala, and thalamus volumes in very preterm children at 8 years: Neonatal pain and genetic variation. Front Behav Neurosci. 2019 doi: 10.3389/fnbeh.2019.00051. 13:51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hermann C, Hohmeister J, Demirakça S, Zohsel K, Flor H. Long-term alteration of pain sensitivity in school-aged children with early pain experiences. Pain. 2006;125(3):278–85. doi: 10.1016/j.pain.2006.08.026. [DOI] [PubMed] [Google Scholar]
- 7.Hohmeister J, Kroll A, Wollgarten-Hadamek I, Zohsel K, Demirakça S, Flor H. Cerebral processing of pain in school-aged children with neonatal nociceptive input: an exploratory fMRI study. Pain. 2010;150(2):257–67. doi: 10.1016/j.pain.2010.04.004. et al. [DOI] [PubMed] [Google Scholar]
- 8.Goffaux P, Lafrenaye S, Morin M, Patural H, Demers G, Marchand S. Preterm births: Can neonatal pain alter the development of endogenous gating systems? Eur J Pain. 2008;12(7):945. doi: 10.1016/j.ejpain.2008.01.003. –. [DOI] [PubMed] [Google Scholar]
- 9.Schmelzle-Lubiecki BM, Campbell KA, Howard RH, Franck L, Fitzgerald M. Long-term consequences of early infant injury and trauma upon somatosensory processing. Eur J Pain. 2007;11(7):799–809. doi: 10.1016/j.ejpain.2006.12.009. [DOI] [PubMed] [Google Scholar]
- 10.Kasala S, Briyal S, Prazad P, Ranjan AK, Stefanov G, Donovan R, Gulati A. Exposure to morphine and caffeine induces apoptosis and mitochondrial dysfunction in a neonatal rat brain. Front Pediatr. 2020;8:593. doi: 10.3389/fped.2020.00593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Alipio JB, Haga C, Fox ME, Arakawa K, Balaji R, Cramer N. Perinatal fentanyl exposure leads to long-lasting impairments in somatosensory circuit function and behavior. J Neurosci. 2021;41(15):3400–17. doi: 10.1523/JNEUROSCI.2470-20.2021. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.McPherson C, Haslam M, Pineda R, Rogers C, Neil JJ, Inder TE. Brain injury and development in preterm infants exposed to fentanyl. Ann Pharmacother. 2015;49(12):1291–7. doi: 10.1177/1060028015606732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Duerden EG, Guo T, Dodbiba L, Chakravarty MM, Chau V, Poskitt KJ. Midazolam dose correlates with abnormal hippocampal growth and neurodevelopmental outcome in preterm infants. Ann Neurol. 2016;79(4):548–59. doi: 10.1002/ana.24601. et al. [DOI] [PubMed] [Google Scholar]
- 14.Rozé JC, Denizot S, Carbajal R, Ancel PY, Kaminski M, Arnaud C. Prolonged sedation and/or analgesia and 5-year neurodevelopment outcome in very preterm infants: Results from the EPIPAGE cohort. Arch Pediatr Adolesc Med. 2008;162(8):728–33. doi: 10.1001/archpedi.162.8.728. et al. [DOI] [PubMed] [Google Scholar]
- 15.Bellù R, Romantsik O, Nava C, de Waal KA, Zanini R, Bruschettini M. Opioids for newborn infants receiving mechanical ventilation. Cochrane Database Syst Rev. 2021;3(3):CD013732. doi: 10.1002/14651858.CD013732.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Campbell JN. APS 1995 Presidential address. Pain Forum. 1996;5(1):85–8. doi: 10.1016/S1082-3174(96)80076-6. [DOI] [Google Scholar]
- 17.Lynch M. Pain as the fifth vital sign. J Intraven Nurs. 2001;24(2):85–94. PMID: 11836838. [PubMed] [Google Scholar]
- 18.Olsson E, Ahl H, Bengtsson K, Vejayaram DN, Norman E, Bruschettini M. The use and reporting of neonatal pain scales: a systematic review of randomized trials. Pain. 2021;162(2):353–60. doi: 10.1097/j.pain.0000000000002046. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ranger M, Johnston CC, Anand KJ. Current controversies regarding pain assessment in neonates. Semin Perinatol. 2007;31(5):283–8. doi: 10.1053/j.semperi.2007.07.003. [DOI] [PubMed] [Google Scholar]
- 20.Avila-Alvarez A, Carbajal R, Courtois E, Pertega-Diaz S, Anand KJ, Muñiz-Garcia J. Grupo español del Proyecto Europain Clinical assessment of pain in Spanish Neonatal Intensive Care Units. Spanish. An Pediatr (Barc) 2016;85(4):181–8. doi: 10.1016/j.anpedi.2015.09.019. [DOI] [PubMed] [Google Scholar]
- 21.Anand KJ, Eriksson M, Boyle EM, Avila-Alvarez A, Andersen RD, Sarafidid K. EUROPAIN survey working group of the NeoOpioid Consortium. Assessment of continuous pain in newborns admitted to NICUs in 18 European countries. Acta Paediatr. 2017;106(8):1248–59. doi: 10.1111/apa.13810. et al. [DOI] [PubMed] [Google Scholar]
- 22.Courtois E, Droutman S, Magny JF, Merchaoui Z, Durrmeyer X, Roussel C. Epidemiology and neonatal pain management of heelsticks in intensive care units: EPIPPAIN 2, a prospective observational study. Int J Nurs Stud. 2016;59:79–88. doi: 10.1016/j.ijnurstu.2016.03.014. et al. [DOI] [PubMed] [Google Scholar]
- 23.Sposito NPB, Rossato LM, Bueno M, Kimura AF, Costa T, Guedes DMB. Assessment and management of pain in newborns hospitalized in a Neonatal Intensive Care Unit: a cross-sectional study. Rev Lat Am Enfermagem. 2017;25:e2931. doi: 10.1590/1518-8345.1665.2931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lago P, Frigo AC, Baraldi E, Pozzato R, Courtois E, Rambaud J. Sedation and analgesia practices at Italian neonatal intensive care units: results from the EUROPAIN study. Ital J Pediatr. 2017;43(1):26. doi: 10.1186/s13052-017-0343-2. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Logier R, Jeanne M, Tavernier B. Method and device for assessing pain in human being – European patent N° 04370029.3. University Hospital of Lille, University of Lille II. Deposit date. 2004. https://patents.google.com/patent/EP1637075A1/en Sep 20. Available from.
- 26.Jeanne M, Logier R, De Jonckheere J, Tavernier B. Validation of a graphic measurement of heart rate variability to assess analgesia/nociception balance during general anesthesia. Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:1840–3. doi: 10.1109/IEMBS.2009.5332598. [DOI] [PubMed] [Google Scholar]
- 27.Faye PM, De Jonckheere J, Logier R, Kuissi E, Jeanne M, Rakza T. Newborn infant pain assessment using heart rate variability analysis. Clin J Pain. 2010;26(9):777–82. doi: 10.1097/ajp.0b013e3181ed1058. et al. [DOI] [PubMed] [Google Scholar]
- 28.Storm H. The development of a software program for analyzing skin conductance changes in preterm infants. Clin Neurophysiol. 2001;112(8):1562–8. doi: 10.1016/s1388-2457(01)00573-9. [DOI] [PubMed] [Google Scholar]
- 29.Storm H. Changes in skin conductance as a tool to monitor nociceptive stimulation and pain. Curr Opin Anaesthesiol. 2008;21(6):796–804. doi: 10.1097/ACO.0b013e3283183fe4. [DOI] [PubMed] [Google Scholar]
- 30.Verweij LM, Kivits JTS, Weber F. The performance of the heart rate variability–derived Newborn Infant Parasympathetic Evaluation Index as a measure of early postoperative pain and discomfort in infants: A prospective observational study. Paediatr Anaesth. 2021;31(7):787–93. doi: 10.1111/pan.14188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Gendras J, Lavenant P, Sicard-Cras I, Consigny M, Misery L, Anand KJS. The newborn infant parasympathetic evaluation index for acute procedural pain assessment in preterm infants. Pediatr Res. 2021;89(7):1840–7. doi: 10.1038/s41390-020-01152-4. et al. [DOI] [PubMed] [Google Scholar]
- 32.Cremillieux C, Makhlouf A, Pichot V, Trombert B, Patural H. Objective assessment of induced acute pain in neonatology with the Newborn Infant Parasympathetic Evaluation index. Eur J Pain. 2018;22(6):1071–9. doi: 10.1002/ejp.1191. [DOI] [PubMed] [Google Scholar]
- 33.Walas W, Latka-Grot J, Maroszyńska I, Malinowska E, Rutkowska M, Piotrowski A. Newborn infant parasympathetic evaluation index for the assessment of procedural pain in nonanesthetized infants: A multicenter ilot study. Am J Perinatol. 2021;38(S 01):e224–e230. doi: 10.1055/s-0040-1709458. et al. Aug. [DOI] [PubMed] [Google Scholar]
- 34.Buyuktiryaki M, Uras N, Okur N, Oncel MY, Simsek GK, Isik SO. Evaluation of prolonged pain in preterm infants with pneumothorax using heart rate variability analysis andEDIN (Échelle Douleur Inconfort Nouveau-Né, neonatal pain and discomfort scale) scores. Korean J Pediatr. 2018;61(10):322–6. doi: 10.3345/kjp.2017.05939. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.de Jesus JAL, Campos Jr D, Storm H, da Rocha AF, Tristão RM. Skin conductance and behavioral pain scales in newborn infants. Psychol Neurosci. 2015;8(2):203–10. doi: 10.1037/h0101058. [DOI] [Google Scholar]
- 36.Pereira-da-Silva L, Virella D, Monteiro I, Gomes S, Rodrigues P, Serelha M. Skin conductance indices discriminate nociceptive responses to acute stimuli from different heel prick procedures in infants. J Matern Fetal Neonatal Med. 2012;25(6):796–801. doi: 10.3109/14767058.2011.587919. et al. [DOI] [PubMed] [Google Scholar]
- 37.Eriksson M, Storm H, Fremming A, Schollin J. Skin conductance compared to a combined behavioural and physiological pain measure in newborn infants. Acta Paediatr. 2008;97(1):27. doi: 10.1111/j.1651-2227.2007.00586.x. –. [DOI] [PubMed] [Google Scholar]
- 38.Tristão RM, Garcia NV, de Jesus JAL, Tomaz C. COMFORT behaviour scale and skin conductance activity: What are they really measuring? Acta Paediatr. 2013;102(9):e402–6. doi: 10.1111/apa.12325. [DOI] [PubMed] [Google Scholar]
- 39.Dalal PG, Doheny KK, Klick L, Britcher S, Rebstock S, Bezinover D. Analysis of acute pain scores and skin conductance measurements in infants. Early Hum Dev. 2013;89(3):153–8. doi: 10.1016/j.earlhumdev.2012.09.008. et al. [DOI] [PubMed] [Google Scholar]
